Efficient Lewis Acid Promoted Alkene Hydrogenations Using Dinitrosyl Rhenium(−I) Hydride Catalysts by Yanfeng Jiang (1873795)

“…Highly efficient alkene hydrogenations were developed using NO-functionalized hydrido dinitrosyl rhenium catalysts of the type [ReH­(PR₃)₂(NO)­(NO­(LA))]­[Z] (<b>2</b>, LA = B­(C₆F₅)₃; <b>3</b>, LA = [Et]⁺, Z = [B­(C₆F₅)₄]⁻; <b>4</b>, LA = [SiEt₃]⁺, Z = [HB­(C₆F₅)₃]⁻; R = <i>i</i>Pr <b>a</b>, Cy <b>b</b>). …”

Efficient Lewis Acid Promoted Alkene Hydrogenations Using Dinitrosyl Rhenium(−I) Hydride Catalysts by Yanfeng Jiang (1873795)

“…Highly efficient alkene hydrogenations were developed using NO-functionalized hydrido dinitrosyl rhenium catalysts of the type [ReH­(PR₃)₂(NO)­(NO­(LA))]­[Z] (<b>2</b>, LA = B­(C₆F₅)₃; <b>3</b>, LA = [Et]⁺, Z = [B­(C₆F₅)₄]⁻; <b>4</b>, LA = [SiEt₃]⁺, Z = [HB­(C₆F₅)₃]⁻; R = <i>i</i>Pr <b>a</b>, Cy <b>b</b>). …”

Efficient Lewis Acid Promoted Alkene Hydrogenations Using Dinitrosyl Rhenium(−I) Hydride Catalysts by Yanfeng Jiang (1873795)

“…Highly efficient alkene hydrogenations were developed using NO-functionalized hydrido dinitrosyl rhenium catalysts of the type [ReH­(PR₃)₂(NO)­(NO­(LA))]­[Z] (<b>2</b>, LA = B­(C₆F₅)₃; <b>3</b>, LA = [Et]⁺, Z = [B­(C₆F₅)₄]⁻; <b>4</b>, LA = [SiEt₃]⁺, Z = [HB­(C₆F₅)₃]⁻; R = <i>i</i>Pr <b>a</b>, Cy <b>b</b>). …”

Efficient Lewis Acid Promoted Alkene Hydrogenations Using Dinitrosyl Rhenium(−I) Hydride Catalysts by Yanfeng Jiang (1873795)

“…Highly efficient alkene hydrogenations were developed using NO-functionalized hydrido dinitrosyl rhenium catalysts of the type [ReH­(PR₃)₂(NO)­(NO­(LA))]­[Z] (<b>2</b>, LA = B­(C₆F₅)₃; <b>3</b>, LA = [Et]⁺, Z = [B­(C₆F₅)₄]⁻; <b>4</b>, LA = [SiEt₃]⁺, Z = [HB­(C₆F₅)₃]⁻; R = <i>i</i>Pr <b>a</b>, Cy <b>b</b>). …”

Efficient Lewis Acid Promoted Alkene Hydrogenations Using Dinitrosyl Rhenium(−I) Hydride Catalysts by Yanfeng Jiang (1873795)

“…Highly efficient alkene hydrogenations were developed using NO-functionalized hydrido dinitrosyl rhenium catalysts of the type [ReH­(PR₃)₂(NO)­(NO­(LA))]­[Z] (<b>2</b>, LA = B­(C₆F₅)₃; <b>3</b>, LA = [Et]⁺, Z = [B­(C₆F₅)₄]⁻; <b>4</b>, LA = [SiEt₃]⁺, Z = [HB­(C₆F₅)₃]⁻; R = <i>i</i>Pr <b>a</b>, Cy <b>b</b>). …”

Fig 7 - by Kayleigh E. Hood (14334045)

“…The onset of playback was associated with a sharp decrease in the numbers of USVs in interactions with robust USVs in the first five minutes. …”

KGF, Leptin, and NRG mRNAs in Ovine Fetal Lungs by Olivier Boucherat (78556)

“…<div><p>RT followed by real-time PCR analysis; mean ± standard error of the mean on six, five, and three individual samples, respectively, in sham-operated control fetuses (C), in a surgical model of CDH (sDH), and in sDH with subsequent tracheal occlusion (sDH + TO). …”

Decline of auditory nerve function in aged CBA/CaJ mice. by Yazhi Xing (327214)

“…<b>B, C, D:</b> Mean wave I amplitude vs. level functions. The data show increased ABR thresholds and decreased wave I amplitudes in aged mice at 11.3, 16, and 22.6 kHz. …”

Ivermectin and albendazole withdrawal period in goat milk by Patrícia Silva Santos (6305066)

Biochemical tests and antitumor effect. by Hui Yu (27723)

“…<p>Figure 5A and B The diagram shows ALT level changes in groups 1 to 4. …”

<em>In Vivo</em> Imaging with Fluorescent Smart Probes to Assess Treatment Strategies for Acute Pancreatitis by Abhiruchi Agarwal (281215)

“…</p> <h3>Methods</h3><p>Edema development and trypsin activation were imaged in a rat caerulein-injection pancreatitis model. A fluorescent “smart” probe, selectively activated by trypsin, was synthesized by labeling with Cy5.5 of a pegylated poly-L-lysine copolymer. …”

Time series at stripe-center. by David M. Holloway (95831)

“…The steady decrease in frequency with increasing rate in (D), with well-populated low to mid rates (blue), follows the trend in the data (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0176228#pone.0176228.g003" target="_blank">Fig 3E and 3F</a>). …”

Example shapes obtained when varying spherical (\lambda_0) and AB polarity (\lambda_1) only. by Silas Boye Nissen (6815351)

The multiple criteria qualitative value-based pricing framework “MARIE” for new clinical status by Akina Takami (16407200)

“…</p> <p>In this study, we applied the value-based pricing framework MARIE to drugs with new clinical status. …”

pHluorin/FusionRed CO₂ response and recovery. by Sandra G. Zimmerman (5062964)

“…This decrease is evident in the second image in panel A and in the graphs in A’ and A”, showing a slight drop in the ratio in the frame starting at 1-minute. …”

Temporal analysis of the inclusion of Physical Education Professionals and Residents in the Brazilian Unified Health System (SUS) from 2009 to 2021 by Leonardo Araújo Vieira (14728266)

Using the spirometry to indicate respiratory exercises for elderly with Parkinson’s disease by Daniela Guimarães (5379710)

Image1_Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers.TIF by Elsbet J. Pieterman (7321421)

“…Mean plasma lipopolysaccharide-binding protein levels were raised with mineral versus corn oil 30 µL/day (12 weeks: 5.8 versus 4.4 μg/ml, p = 0.03; 16 weeks: 5.8 versus 4.5 μg/ml, p = 0.09), indicating increased intestinal bacterial endotoxin absorption and potential pro-inflammatory effects. …”

DataSheet1_Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers.docx by Elsbet J. Pieterman (7321421)

“…Mean plasma lipopolysaccharide-binding protein levels were raised with mineral versus corn oil 30 µL/day (12 weeks: 5.8 versus 4.4 μg/ml, p = 0.03; 16 weeks: 5.8 versus 4.5 μg/ml, p = 0.09), indicating increased intestinal bacterial endotoxin absorption and potential pro-inflammatory effects. …”

<i>apterous</i> enhancer analysis. by Johannes Stratmann (2697598)

“…(L) Quantification of β-gal levels in the dAp cells, shows that the same mutations of potential TFBS, lead to a significant decrease of the <i>apSJ2-CRM</i> activity in dAp cells, when compared to control levels (_*** p≤0.0001, n = 16 cells, Students t-test, +/- SEM). …”